Prevention and management of side effects, key to comprehensive treatment of acute myeloid leukemia

“The patient with acute myeloid leukemia (AML) has a median age of 67 years, which tells us that 2 out of 3 patients will be over 60 years of age,” says Josefina Serrano, a hematologist at Reina Sofía de Córdoba University Hospital. “Many of them can therefore present other diseases, not be able to receive intensive chemotherapy and even have already overcome other cancers, with the physical and emotional wear that this entails.” In the last dec…